Hasil Pencarian (2)
biotech | CAS: 1905409-39-3
Mosunetuzumab is a humanized anti-CD20/CD3 bispecific antibody.[L42230] It can recognize and bind two different targets simultaneously, CD20 on cancer B-cells and CD3 on T-cells, allowing it to redirect T-cell cytotoxic activity to cancer cells.[A249320] The …
Kategori:
Amino Acids, Peptides, and ProteinsAntibodies, MonoclonalAntibodies, Monoclonal, Humanized
+13
Target Protein:
B-lymphocyte antigen CD20T-cell surface glycoprotein CD3 epsilon chain
Waktu ParuhMosunetuzumab has a…
Vol. DistribusiThe estimated centr…
KlirensThe mean steady-sta…
Genetik
-
biotech | CAS: 1823078-37-0
Tisagenlecleucel is a CD19-directed genetically modified autologous T cell immunotherapy, or a CAR-T cell therapy for B-cell acute lymphoblastic leukemia. It was granted approval by FDA in August 2017 under the market name Kymriah. Tisagenlecleucel is an immu…
Kategori:
Amino Acids, Peptides, and ProteinsAntineoplastic AgentsAntineoplastic Agents, Immunological
+10
Target Protein:
B-lymphocyte antigen CD19
Waktu ParuhThe mean half life …
Vol. DistribusiThe drug is found t…
Klirens-
Genetik
-